India’s first indigenous CAR-T cell therapy, NexCAR19, developed by ImmunoACT, an IIT Bombay spin-off, marks a major leap in ...

The increasing need for purified, high-quality plasmid DNA for gene therapy, vaccine production, and molecular biology applications is driving market expansion. The ongoing adoption of innovative ...

Bharat Biotech expands into advanced biologics with Nucelion Therapeutics, a new CRDMO for cell and gene therapy manufacturing, positioning India as a rising hub for global biotherapeutics.

Investing.com -- 4basebio PLC (AIM:4BB) stock surged 6.9% on Monday after announcing that a global Tier 1 pharmaceutical partner has begun dosing patients in Phase I/II clinical trials using the ...

Once an antibody latches on to a pathogen, broadly neutralizing antibodies inactivate it (as their name implies). This is ...

Genenta Science shares surged 300% in premarket trading on Friday after announcing an expanded collaboration with ANEMOCYTE. ・The partnership aims to advance an off-the-shelf LVV Plasmid DNA platform ...

The partnership leverages Genenta's robust and well-tested LVV Plasmid DNA technology, a platform developed from the foundational research of Professor Luigi Naldini, co-founder of Genenta. This ...

According to Towards Healthcare data, the plasmid purification market size is estimated at USD 1.95 billion in 2024, growing to USD 2.18 billion in 2025, and is projected to reach approximately USD ...

This guide provides an in-depth exploration of the essential role plasmids play in biotechnology and genetic engineering. From foundational concepts to the complexities of high-throughput production, ...

Plasmids are an essential tool in genetic engineering, gene therapy, vaccine research and more. Successful plasmid DNA production relies on many factors – including the type of vector, the host strain ...